The Conquest of TUBERCULOSIS

The Conquest of Tuberculosis

Volumn , Issue , 2023, Pages 1-242

  Waksman, Selman A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85164873696     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1525/9780520328471     Document Type: Book

References (166)

1. Anonymous 1958. Tuberculosis Chart Series. Washington, D.C.: U.S. Department of Health, Education and Welfare, Public Health Service.
2. Anonymous 1960. World Health Organization Expert Committee on Tuberculosis: 7th Report. Tech. Rept. No. 195.
3. Anonymous 1961a. The Glaxo Volume, No. 22, 21-28. Middlesex, England: Glaxo Labs., Ltd.
4. Anonymous1961b. Transactions of the 2.0th Research Conference in Pulmonary Diseases. Washington, D.C.: Veterans Administration, Dept. of Medicine and Surgery.
5. Anonymous 1961c. Tuberculosis Chart Series. Washington, D.C.: U.S. Department of Health, Education and Welfare, Public Health Service.
6. Anonymous 1962a. Chest and Health Bulletin (editorial), Dec., 1962, pp. 176-177. London: The Chest and Heart Association.
7. Anonymous 1962b. "Tuberculosis Research" (editorial), World Health Organization Chronicle, 16:42-45.
8. Anonymous 1962c. World Health Organization Epidemiological and Vital Statistics Report (Geneva), 15:327-388.
9. Anonymous 1963. Quarterly Progress Report of the Veterans Administration— Armed Forces Study on Chemotherapy of Tuberculosis, April. Washington, D.C.: Veterans Administration, Dept. of Medicine and Surgery.
10. Amberson, J. B., Jr., McMahon, B. T., and Pinner, M. 1931. "A Clinical Trial of Sanocrysin in Pulmonary Tuberculosis," Amer. Rev. Tuberc., 24:401-435.
11. Aronson, J. D., and Aronson, C. F. 1952. "Appraisal of Protective Value of BCG Vaccine," four. Amer. Med. Assoc., 149:334-343.
12. Ashburn, P. M. 1947. The Ranfks of Death. New York: Coward-McCann.
13. Augier, J. 1961. "Results and Interpretations of Cultures and Drug Susceptibility Depending on Treatment Before Admission to the Santorium (A Statistical Study of 464 Cases of Pulmonary Tuberculosis)," Rev. Tuberc. (Paris), 25:590-617.
14. Babcock, R. H. 1907. Diseases of the Lungs. New York: D. Appleton.
15. Babès, V. 1889. "Sur les associations bactériennes de la tuberculose," in Congrès pour l'Etude de la Tuberculose, 1888, (Paris), pp. 542-56.
16. Baldwin, E. R. 1913. "Tuberculosis: History and Etiology," in W. Osier and T. McCrae, Modern Medicine, 2d. ed., I, 287-338. New York: Lea & Febriger.
17. Barber, M. 1951. "Medical Services in the Soviet Union," Lancet, 261:775-778.
18. Barnett, T. B., et al. 1960. "The Chemotherapeutic Management of Treatment Failures and Relapses in Pulmonary Tuberculosis," Amer. Rev. Resp. Dis., 82:751-752.
19. Barnwell, J. 1952. "Presentation of Trudeau Medal to Dr. Amberson," in National Tuberculosis Association, Transactions, 48th Annual Meeting, pp. 1-6.
20. Bentley, P. 1948. The Brontes. Denver: Alan Swallow.
21. Bernard, E. 1962. "Évolution de la chimiothérapie antibacillaire au cours des dix dernières années," Acta Phtisiol. (Paris), pp. 3-11.
22. Biggs, H. M. 1888-1889. "The Principles of Treatment in Pulmonary Tuberculosis, with Some Observations of Its Etiology," Buffalo Med. & Surg, Jour., 28:633.
23. Brightman, I. J., and Hilleboe, H. E. 1962. "The Present Status of Tuberculosis Control," Amer, Jour. Pub. Health, 52:749-758.
24. Bernard, E. 1962. "Évolution de la chimiothérapie antibacillaire au cours des dix dernières années," Acta Phtisiol. (Paris), pp. 3-11.
25. Biggs, H. M. 1888-1889. "The Principles of Treatment in Pulmonary Tuberculosis, with Some Observations of Its Etiology,"., 28:633.
26. Brightman, I. J., and Hilleboe, H. E. 1962. "The Present Status of Buffalo Med. & Surg, Jour Tuberculosis Control," Amer, Jour. Pub. Health, 52:749-758.
27. Brown, C. A. 1937. Life of John Keats. London: Oxford Univ. Press.
28. Brown, L. 1941. The Story of Clinical Pulmonary Tuberculosis. Baltimore: Williams & Wilkins Co.
29. Brownlee, J. 1918. An Investigation into the Epidemiology of Phthisis in Great Britain and Ireland. London: Medical Research Council.
30. Bunn, P. A. 1947. Streptomycin in the Treatment of Tuberculosis. Washington, D.C.: Conference on Antibiotic Research.
31. Bunn, P. A. 1949. "Tuberculous Meningitis," Natl. Tuberc. Assoc. Bull., October, p. 135.
32. Canby, H. S. 1939. Thoreau. Boston: Houghton Mifflin Co.
33. Canetti, G. 1962a. "Summary by the Chairman," Bull. Intern. Union against Tuberc., 32:698-699.
34. Canetti, G. 1962b. "The Eradication of Tuberculosis: Theoretical Problems and Practical Solutions," Tubercle, 43(3): 301-321.
35. Cantani, A. 1885. "Tentativi di bacterioterapia," Riforma Medica Napoli, p. 147.
36. Castiglioni, A. 1933. Historv of Tuberculosis. New York: Medical Life Press.
37. Chaves, A. D., et al. 1961. "The Prevalence of Drug Resistance among Strains of M. tuberculosis Isolated from Ambulatory Patients in New York City," Amer. Rev. Resp. Dis., 84:744.
38. Clark, P. F. 1961. Pioneer Microbiologists of America. Madison: Univ. of Wisconsin Press.
39. Cocchi, C. 1948. "Terapia della tuberculosi con streptomicina solfone e vitamina A (Tuberculosi miliare e meningite tubercolare)," Riv. Clin. Ped., 46:1-67.
40. Cooke, R. E., Dunphy, D. L., and Blake, F. G. 1946. "Streptomycin in Tuberculous Meningitis: Report of Its Use in One-Year-Old Infant," Yale four. Biol. Med., 18: 221-226.
41. Cooper, D. A. 1953. "Presidential Remarks," in National Tuberculosis Association, Transactions, 49th Annual Meeting, pp. 18-21.
42. Crofton, J. 1960. "The Chemotherapy of Tuberculosis, with Special Reference to Patients Whose Bacilli Are Resistant to the Standard Drugs," Brit. Med. Bull., 16:55-60.
43. Cummins, S. L. 1949. Tuberculosis in History. London: Bailliere, Tindall and Cox.
44. Debré, R., and Brissaud, H. E. 1953. Meningite tuberculeuse et tuberculose miliaire de l'enfant. Paris: Masson & Cie.
45. Drabkin, I. E. 1950. Caelius Aurelianus. De morbis chronicis. On Acute Diseases and on Chronic Diseases. Chicago: Univ. of Chicago Press.
46. Drolet, G. J. 1923. "100,000 Victims of Tuberculosis," Bull. N.Y. Tubere. Assoc., 4(3):17-21.
47. Drolet, G. J. 1946. "Epidemiology of Tuberculosis," in B. Goldberg, ed., Clinical Tuberculosis, pp. A3-A70d. Philadelphia: F. A. Davis Co.
48. Drolet, G. J., and Lowell, A. M. 1955. "Whereto Tuberculosis? The First Seven Years of the Antimicrobial Era, 1947-1953," Amer. Rev. Tuberc., 72: 419-452.
49. Drolet, G. J., and Lowell, A. M. 1962. "Tuberculosis Mortality among Children: The Last Stage," Dis. of the Chest, 42:364-371.
50. Dubos, R., and Dubos, J. 1952. The White Plague: Tuberculosis, Man and Society, Boston: Little, Brown & Co.
51. Ebstein, E. 1932. Tuberkulose als Schicksal. Stuttgart: Ferdinand Enke Verlag.
52. Ellis, A. E. 1959. The RadBoston: Little, Brown & Co.
53. Fanconi, G., and Löffler, W. 1948. Streptomycin und Tuberkulose. Basel: Benno Schwabe Verlag.
54. Feldman, W. H. 1954. "Streptomycin: Some Historical Aspects of Its Development as a Chemotherapcutic Agent in Tuberculosis," Amer. Rev. Tuberc., 69:859-868.
55. Feldman, W. H., Hinshaw, H. C., and Mann, F. C. 1945. "Streptomycin in Experimental Tuberculosis," Amer. Rev. Tuberc., 52:269-298.
56. Fishberg, M. 1932. Pulmonary Tuberculosis. 3d ed. New York: Lea & Febiger.
57. Flick, L. F. 1925. Development of Our Knowledge of Tuberculosis. Philadelphia: Wickersham Printing Co.
58. Florey, M. E. 1961. The Clinical Application of Antibiotics. Vol. II. Streptomycin and Other Antibiotics Active against Tuberculosis. London: Oxford Univ. Press.
59. Forlanini, C. 1894. "A contribuzione della terapia chirurgica della tisi ablazione del polmone? Pneumotorace artificiale?" Gazz. Med. di Torino, 45:381-384, 401-403.
60. Fouquet, J., et al. 1949. "Résultats de deux ans de traitement de la méningite tuberculeuse de l'enfant par la streptomycine au Centre de la Salpêtrière," Bull. Mém Soc. Méd. Hôpitaux Paris, 65:13-14, 553-557.
61. France, Anatole 1924. The Latin Genius. Trans. Wilfrid S. Jackson. New York: Dodd, Mead & Co.
62. Gratia, A. 1948. "Leçons à tirer de la conférence interuniversitaire sur le traitement par la streptomycine des méningites tuberculeuses et de la granulie," Rev. Méd. Liège, 4:48-51.
63. Guasch, E. A. 1963. "Evolución de la morbilidad tuberculosa, durante veinte años, vista desde un dispensario," lnst. Antituberculoso "Francisco Moragas," 15:29-40.
64. Hale-White, W. 1938. Keats as Doctor and Patient. New York and London: Oxford Univ. Press.
65. Hart, P. D. 1946. "Chemotherapy of Tuberculosis Research during the Past 100 Years," Brit. Med. Jour., 2:805-810.
66. Hill, L. 1960. "The Conquest of Tuberculosis," Amer. Rev. Resp. Dis., 82:291-294.
67. Hilleboe, H. E., and Brightman, I. J. 1961. Editorial, "The Big Push Ahead in Tuberculosis Control," Amer. Rev. Resp. Dis., 84:893-898.
68. Hinshaw, H. C. 1954. "Historical Notes on Earliest Use of Streptomycin in Clinical Tuberculosis," Amer. Rev. Tuberc., 70:9-14.
69. Hinshaw, H. C. 1955. "Progress in Tuberculosis Therapy," Jour. Amer. Med. Assoc., 158:832.
70. Hinshaw, H. C., Feldman, W. H., and Pfuetze, K. H. 1946. "Treatment of Tuberculosis with Streptomycin," Jour. Amer. Med. Assoc., 132:778-782.
71. Hinshaw, H. C., and Garland, L. H. 1963. Diseases of the Chest. 2d ed. Philadelphia: W. B. Saunders Co.
72. Hirsch, A. 1883. Handbook of Geographical and Historical Pathology. Trans. Charles Creighton. London: New Sydenham Society. Vol. III.
73. Hobby, G. L. 19620. "Prospects for a Vaccine against Tuberculosis," NTA Bull., May, pp. 12-13.
74. Hobby, G. L 1962b. "Primary Drug Resistance in Tuberculosis," Amer. Rev. Resp. Dis., 86:839-846.
75. Holm, J. 1962. "The Eradication of Tuberculosis," Dis. of the Chest, February, pp. 18-21.
76. Hornung, S. 1962. "L'état actuel de l'endémie tuberculeuse et la question de son éradication en Pologne: Le rôle de la législation antituberculeuse," Bull. Intern. Union against Tuberc., 32: 683-688.
77. Huber, J. B. 1906. Consumption: Its Relation to Man and His Civilization. Philadelphia: J. B. Lippincott Co.
78. Jacobson, A. C. 1926, Genius: Some Revaluations. New York: Adelphi Publications.
79. Keefer, C. S., et al. 1946. "Streptomycin in the Treatment of Infections: A Report of One Thousand Cases," Jour. Amer. Med. Assoc., 132: 4-11, 70-77.
80. Kervran, R. 1960. Laënnec: His Life and Times. Trans. D. C. Abrahams-Curiel. New York and London: Pergamon Press.
81. Klebs, T. A. E. 1873. "Die künstliche Erzeugung der Tuberkulose," Arch. Exper. Pathol. Pharmacol., 1:163-180.
82. Koch, R. 1932. The Aetiology of Tuberculosis. New York: National Tuberculosis Assoc.
83. Krafchik, L. L. 1946. "Tuberculous Meningitis Treated with Streptomycin," Jour. Amer. Med. Assoc., 132:375-376.
84. Krafchik, L. L. 1948. Staff proceedings, St. Peter's General Hospital, New Brunswick, N.J., July.
85. Krause, A. K. 1928. "Tuberculosis and Public Health," Amer. Rev. Tuberc., 18:271-322.
86. Krause, A. K. 1932. "Introduction to the Aetiology of Tuberculosis," Amer. Rev. Tuberc. 25:285-298.
87. Laënnec, R. T. H. 1819. De l'auscultation médiate. Tran, by H. Théophile. 2 vols. Paris: J. A. Brosson. London: J. Bale Sons & Danielson, Ltd., 1923.
88. Lehmann, J. 1946. "Para-aminosalicylic Acid in the Treatment of Tuberculosis," Lancet, 251:15-16.
89. Lehmann, J 1949. "The Treatment of Tuberculosis in Sweden with Paraaminosalicylic Acid (PAS): A Review," Dis. of the Chest., 16:684-703.
90. Lincoln, E. M. 1947. "Tuberculous Meningitis in Children," Amer. Rev. Tuberc., 56:75.
91. Lincoln, E. M. 1961. "Eradication of Tuberculosis in Children," Arch. Environm. Health, 3:444-455.
92. Lincoln, E. M., Sordillo, S. V. R., and Davies, P. A. 1960. "Tuberculous Meningitis in Children: A Review of 167 Untreated and 74 Treated Patients with Special Reference to Early Diagnosis," Jour. Pediat., 57:807-823.
93. Lindsay, D. R., and Allen, E. M. 1961. "Medical Research: Past Support, Future Directions," Science, 134:2017-2024.
94. Long, E. R. 1928. A History of Pathology. Baltimore: Williams & Wilkins Co.
95. Long, E. R. 1940a. "The Decline of Tuberculosis, with Special Reference to Its Generalized Form," Bull. History of Med., 8:819-843.
96. Long, E. R. 1940b. "Weak Lungs on the Santa Fe Trail," Bull. History of Med., 8:1040-1054.
97. Long, E. R. 1953. "Tuberculosis in Modern Society," Bull. History of Med., 27:301-319.
98. Long, E. R. 1958. The Chemistry and Chemotherapy of Tuberculosis. Baltimore: Williams & Wilkins Co.
99. Long, E. R., et al. 1957. "Report of Ad Hoc Advisory Committee on BCG to the Surgeon General of the United States Public Health Service," Amer. Rev. Tuberc., 76:726-731.
100. Lorber, J. 1949. "A Study of Ten Children after Treatment with Streptomycin for Tuberculous Meningitis," Arch. Dis. Childhood, 24:289-293.
101. Lorber, J. 1954. "The Results of Treatment of 549 Cases of Tuberculous Meningitis," Amer. Rev. Tuberc., 69:13-25.
102. Lorber, J. 1956. "Current Results in Treatment of Tuberculous Meningitis and Miliary Tuberculosis," Brit. Med. Jour., 1:1009-1011.
103. Louis, P. C. A. 1844. Researches on Phthisis. Trans. W. H. Walshe. 2d ed. London: Sydenham Society.
104. Lowell, A. M. 1960. Tuberculosis in New York City, 1959. New York: New York Tuberculosis and Health Assoc.
105. Lowell, A. M. 1962. Tuberculosis in New York City, 1961. New York: New York Tuberculosis and Health Assoc.
106. McDermott, W. 1960. "Antimicrobial Therapy of Pulmonary Tuberculosis," Bull. World Health Org., 23:427-461. Also in: 1962. Amer. Rev. Resp. Dis., 86:323-335.
107. McDermott, W., et al. 1947. "Streptomycin in the Treatment of Tuberculosis in Humans: (I) Meningitis and Generalized Hematogenous Tuberculosis," Ann. Intern. Med., 27:769-822.
108. McDougall, J. B. 1949. Tuberculosis: A Global Study in Social Pathology. Edinburgh: E. & S. Livingstone, Ltd.
109. MacGregor, I. M. 1962. "Where We Stand in Scotland," in Tuberculosis—Prevention and Control. London: The Chest and Heart Association.
110. MacLeod, J. 1956. "Streptomycin and Dihydrostreptomycin," Practitioner, 176:5-13.
111. Magarlo, M. F., et al. 1961. "The Problem of the Resistance of M. tuberculosis to Standard Drugs in Rio de Janeiro, Brazil," Adv. Tuberc. Res., 11:193-213.
112. Marks, J. 1925. Genius and Disaster. New York: Adelphi Publications. Also: 1928. London: John Hamilton, Ltd.
113. Millin, S. G. 1933. Cecil Rhodes. New York: Harper & Bros.
114. Mjfllgaard, H. 1924. Chemotherapy of Tuberculosis. Copenhagen: Nyt Nordisk Forlag.
115. Moorman, L. J. 1940. Tuberculosis and Genius. Chicago: Univ. of Chicago Press.
116. Munro, D. G. M. 1926. The Psycho-pathology of Tuberculosis. London: Oxford Univ. Press.
117. Myers, J. A. 1927. Fighters of Fate. Baltimore: Williams & Wilkins Co.
118. Nannotti, A. 1893. "Osservazione clinica e ricerche sperimentali intorna alla influenza delle infiammazioni da streptococco nelle affecioni tuberculari" (abstracted), Centr. Bakteriol., 14: 601-602.
119. Nicolson, D. W. 1943. Twenty Years of Medical Research. New York: National Tuberculosis Assoc.
120. Ochs, C. W. 1962. "The Epidemiology of Tuberculosis," four. Amer. Med. Assoc., 179:247.
121. Perla, D. and Marmorston, J. 1941. Natural Resistance and Clinical Medicine. Boston: Little, Brown & Co.
122. Pfuetze, K. H., et al. 1955. "The First Clinical Trial of Streptomycin in Human Tuberculosis," Amer. Rev. Tuberc., 71:752-754.
123. Piery, A. M., and Roshem, J. 1931. Histoire de la tuberculose. Paris: G. Dion & Cie.
124. Porot, M. 1950. La psycholgie des tuberculeux. Paris: Delachaux & Niestle.
125. Prasad, B. G. 1961. "Pulmonary Tuberculosis in India," Brit. four. Dis. Chest, 55:169-184.
126. Puig, C. X. 1963. Viejos y nuevos problemas de la tuberculosis," Inst. Antituberculoso "Francisco Moragas," 15:61-91
127. Rappin, M. 1912. "Action exercée par les diastases de quelques espèces saprophytes sur la tuberculose experimentale du cobaye," Gaz. Méd. de Nantes, pp. 958-960.
128. Rapport, S., and Wright, H. 1952. Great Adventures in Medicine. New York: Dial Press.
129. Remarque, E. M. 1961. Heaven Has No Favorites. New York: Harcourt, Brace.
130. Rich, A. R. 1951. The Pathogenesis of Tuberculosis. 2d ed. Springfield, 111.: Charles C. Thomas.
131. Riggins, H. M., and Hinshaw, H. C. (eds.) 1949. Streptomycin and Dihydrostreptomycin in Tuberculosis. New York: National Tuberculosis Assoc.
132. Riley, R. L., et al. 1962. "Infectiousness of Air from a Tuberculosis Ward," Amer. Rev. Resp. Dis., 85:511-525. Also: 1962. Adv. Tuberc. Res., 12:150-190.
133. Rolleston, J. D. 1941. "The Folk-lore of Pulmonary Tuberculosis," Tubercle, 22:55-65.
134. Schatz, A., Bugie, E., and Waksman, S. A. 1944. "Streptomycin, a Substance Exhibiting Antibiotic Activity against Gram-Positive and Gram-Negative Bacteria," Proc. Soc. Exper. Biol. Med., 55:66-69.
135. Schatz, A., and Waksman, S. A. 1944. "Effect of Streptomycin and Other Antibiotic Substances upon Mycobacterium tuberculosis and Related Organisms," Proc. Soc. Exper. Biol. Med., 57:244-248.
136. Shattuck, L. 1850. Report of the Sanitary Commission of Massachusetts. (Reprinted Harvard University Press, 1948.)
137. Shryock, R. H. 1957. National Tuberculosis Association, 1904-1954: A Study of the Voluntary Health Movement in the United States. New York: National Tuberculosis Assoc.
138. Sjöberg, J. E., and Tivenius, L. 1961. "Late Results of Thoracoplasties in Combination with Chemotherapy in the Treatment of Tuberculosis," Acta. Tuberc. Scand., 40: 202-214.
139. Smith, D. T. 1953. "The Broad View: The Tuberculosis Problem in the United States," in National Tuberculosis Association, Transactions, 49th Annual Meeting, pp. 30-34.
140. Smith, G. 1941. Plague on Us. New York: The Commonwealth Fund.
141. Soper, F. L. 1962. "Problems To Be Solved If the Eradication of Tuberculosis Is To Be Realized," Amer. four. Pub. Health, 52: 734-745. Also: 1962. Bull. Nat. Tuberc. Assoc., June, pp. 9-12.
142. Stern, B. J. 1941. Society and Medical Progress. Princeton: Princeton Univ. Press.
143. Tellesson, W. G. 1960. "Changing Concepts in the Treatment of Tuberculosis (Part I)," Med Jour. Australia, 2:1005-1007.
144. Tillett, W. S. 1948. "The Antibiotic Age," editorial, Amer. Jour. Med., 4:159-162.
145. Truant, J. P., Brett, W. A., and Thomas, W., Jr. 1962. "Fluorescence Microscopy of Tubercle Bacilli Stained with Auramine and Rhodamine," Henry Ford Hosp. Med Bull., 10:287-296.
146. Trudeau, E. L. 1916. An Autobiography. New York: Doubleday, Page & Co. Also: 1928. New York: National Tuberculosis Assoc.
147. Vaudremer, A. 1913. "Action de l'extrait filtré d'Aspergillus fumigatus sur les bacilles tuberculeux," Compt. Rend. Soc. Biol., 74:278-280.
148. Villemin, J. A. 1865. "Cause et nature de la tuberculose: Son inoculation de l'homme au lapin," Compt. Rend. Acad. Sei., 61:1012-1015.
149. Villemin, J. A. 1868. Études sur la tuberculose. Paris: J. B. Ballière.
150. Waksman, S. A. 1945. "Planned Research in Biology, with Special Reference to Antibiotic Substances," Hearings on Science Legislation before the Subcommittee of the Committee on Military Affairs, U.S. Senate, 79th Congress, November 1-2.
151. Waksman, S. A 1947. "Antibiotics and Tuberculosis," Jour. Amer. Med. Assoc., 135:478-485.
152. Waksman, S. A 1954. "Tenth Anniversary of the Discovery of Streptomycin, the First Chemotherapeutic Agent Found To Be Effective against Tuberculosis in Humans," Amer. Rev. Tuberc., 70:1-8.
153. Waksman, S. A., Bugie, E., and Schatz, A. 1944. "Isolation of Antibiotic Substances from Soil Microorganisms, with Special Reference to Streptothricin and Streptomycin," Proc. Staff Meet. Mayo Clinic, 19:537-548.
154. Waksman, S. A., and Curtis, R. 1916. "The Actinomyces of the Soil," Soil Sci., 1:99-134.
155. Waksman, S. A., and Henrici, A. T. 1943. "The Nomenclature and Classification of the Actinomycetes," Jour. Bacteriol., 46:337-341.
156. Waksman, S. A., and Woodruff, H. B. 1942. "Streptothricin, a New Selective Bacteriostatic and Bactericidal Agent, Particularly Active against Gram-Negative Bacteria," Proc. Soc. Exper. Biol. Med., 49:207-20.
157. Waring, J.J. 1953. "On Receipt of the Trudeau Medal," in National Tuberculosis Association, Transactions, 49th Annual Meeting, PP- 3-5.
158. Webb, G. B. 1936. Tuberculosis. New York: Paul B. Hoeber.
159. Weber, J. C. P., et al. 1963. "Long-Term Antibacterial Treatment for Pulmonary Tuberculosis in Patients Older than 5o Years," Amer. Rev. Resp. Dis., 87:116-119.
160. Wilson, J. L. 1954. "The Future of Tuberculosis," in Quarterly Progress Report of the Veterans Administration—Army-Navy Study on the Chemotherapy of Tuberculosis, October. Washington, D.C.
161. Wolff, G. 1938. "Tuberculosis and Civilization: I. Basic Facts and Figures in the Epidemiology of Tuberculosis," Human Biology, 10:106-123.
162. Wolff, G. 1938. "Tuberculosis and Civilization: II. Interpretation of the Etiological Factors in the Epidemiology of Tuberculosis," Human Biology, 10:251-284.
163. Woodruff, H. B., and Foster, J. W. 1944. "In vitro Inhibition of Mycobacteria by Streptothricin," Proc. Soc. Exper. Biol. Med., 57:88-89.
164. Yeager, R. L. 1962. "TB State of the Union—1962," Nat. Tuberc. Assoc. Bull., July-August, pp. 3-5.
165. Zorini, A. O. 1962. "Inaugurazione del 2° cours d'epidemiologie et de lutte contre la tuberculose pour medecins Italiens et étrangers," Ann. dell'Istituto Carlo Forlanini, 22:3-10.
166. Zorzoli, G. 1940. "Influenza dei filtrati di alcuni miceti sul Bacillo tubercolare umano e bovino," Ann. dell'lnstituto Carlo Forlanini, 4:208-220, 221-237.